S Valtuena
Overview
Explore the profile of S Valtuena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franzini L, Ardigo D, Valtuena S, Pellegrini N, Del Rio D, Bianchi M, et al.
Nutr Metab Cardiovasc Dis
. 2010 Aug;
22(1):50-7.
PMID: 20674303
Background And Aims: Oxidative stress has been advocated as a major cause for cardiovascular disease (CVD), and low plasma antioxidant concentrations are associated with endothelial dysfunction, the first step towards...
2.
Del Rio D, Valtuena S, Pellegrini N, Bianchi M, Ardigo D, Franzini L, et al.
Eur J Clin Nutr
. 2009 Jun;
63(10):1220-5.
PMID: 19536163
Background And Objectives: A cross-sectional observation suggests that total antioxidant capacity (TAC) of the diet positively affects plasma concentrations of beta-carotene independent of beta-carotene intake. This study was carried out...
3.
Pellegrini N, Valtuena S, Ardigo D, Brighenti F, Franzini L, Del Rio D, et al.
Nutr Metab Cardiovasc Dis
. 2009 Apr;
20(1):64-71.
PMID: 19361969
Background And Aims: It has been suggested that lignan intake may decrease the risk for cardiovascular disease (CVD) by modifying traditional risk factors as well as aortic stiffness. However, the...
4.
Ardigo D, Stuehlinger M, Franzini L, Valtuena S, Piatti P, Pachinger O, et al.
Eur J Clin Invest
. 2007 Mar;
37(4):263-9.
PMID: 17373961
Background: Increased plasma concentrations of asymmetric dimethylarginine (ADMA) contribute to impair endothelial function in patients with established cardiovascular disease (CVD) and/or individuals with clinical syndromes known to increase CVD. However,...
5.
Valtuena S, Del Rio D, Pellegrini N, Ardigo D, Franzini L, Salvatore S, et al.
Eur J Clin Nutr
. 2006 Jul;
61(1):69-76.
PMID: 16835597
Objective: To investigate the contribution of the total antioxidant capacity (TAC) of the diet to plasma concentrations of beta-carotene. Design: Cross-sectional study. Setting: Department of Public Health and Department of...
6.
Zavaroni I, Numeroso F, Dongiovanni P, Ardigo D, Valenti L, Fracanzani A, et al.
Metabolism
. 2003 Dec;
52(12):1593-6.
PMID: 14669161
To address the potential role that tumor necrosis factor-alpha (TNF-alpha) might play in modulation of insulin resistance in healthy, nondiabetic individuals, we compared plasma TNF-alpha and soluble TNF-alpha receptor 2...
7.
Valtuena S, Di Mattei V, Rossi L, Polito A, Cuzzolaro M, Branca F
Eur J Clin Nutr
. 2003 Feb;
57(2):260-5.
PMID: 12571657
Objective: To assess the impact of anorexia nervosa and that of nutritional rehabilitation on bone resorption. Design: Cross-sectional, observational study. Setting: Rome, Italy Subjects: Twenty-eight female patients affected by anorexia...
8.
Branca F, Spagnoli A, Cianfarani S, Spadoni G, Golden M, Boscherini B, et al.
J Pediatr Endocrinol Metab
. 2002 Feb;
15(1):27-34.
PMID: 11826867
The aim of this study was to evaluate the effect of growth hormone (GH) treatment on bone resorption in children with GH deficiency and those with idiopathic short stature. The...
9.
Valtuena S, Sette S, Branca F
Int J Vitam Nutr Res
. 2001 Oct;
71(3):189-202.
PMID: 11582842
No abstract available.
10.
Valtuena S, Kehayias J
Med Clin (Barc)
. 2001 Jun;
116(15):590-7.
PMID: 11412637
No abstract available.